APELIAN DAVID (COO and Ex. Medical Officer) sold 31.3% of their position (5K shares) of EIGER BIOPHARMACEUTICALS, INC. on the open market
Open‑market sale worth $49.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/18/2022ACC: 0001567619-22-016461
DirectorOfficer· COO and Ex. Medical Officer
Since Mar 2019
-5K
Net shares
Net seller
$49.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$9.81
Trade value
$49.03K
% of position
31.3%
8/16/2022
16K→11K
Total
Net shares
−5K
Net value
-$49.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2022 | S · Sale | −5K | $9.81 | $49.03K | 31.3% | 16K | 11K |
| Total | −5K | -$49.03K | ||||||
Derivative Transactions0
No derivative transactions reported